AIM ImmunoTech Inc.

AIM · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$17-$29-$19-$19
Dep. & Amort.$0$0$0$1
Deferred Tax$0$6$0-$2
Stock-Based Comp.$1$0$1$2
Change in WC$0$1$1$1
Other Non-Cash$1$0$1$4
Operating Cash Flow-$15-$21-$16-$14
Investing Activities
PP&E Inv.-$0-$1-$0-$1
Net Acquisitions$0$0$4$1
Inv. Purchases-$0-$2-$3-$23
Inv. Sales/Matur.$6$1$10$22
Other Inv. Act.-$1$0$0-$0
Investing Cash Flow$5-$1$11-$1
Financing Activities
Debt Repay.$2$0$0-$5
Stock Issued$1$0$0$13
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$3$0$0$0
Financing Cash Flow$6$0$0$8
Forex Effect$0$0$0$0
Net Chg. in Cash-$4-$22-$5-$6
Supplemental Information
Beg. Cash$5$27$32$39
End Cash$2$5$27$32
Free Cash Flow-$15-$22-$16-$15